These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 10786693
1. Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells. Boffa LC, Scarfi S, Mariani MR, Damonte G, Allfrey VG, Benatti U, Morris PL. Cancer Res; 2000 Apr 15; 60(8):2258-62. PubMed ID: 10786693 [Abstract] [Full Text] [Related]
2. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Cutrona G, Carpaneto EM, Ulivi M, Roncella S, Landt O, Ferrarini M, Boffa LC. Nat Biotechnol; 2000 Mar 15; 18(3):300-3. PubMed ID: 10700145 [Abstract] [Full Text] [Related]
3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M. Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214 [Abstract] [Full Text] [Related]
4. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Brandén LJ, Mohamed AJ, Smith CI. Nat Biotechnol; 1999 Aug 01; 17(8):784-7. PubMed ID: 10429244 [Abstract] [Full Text] [Related]
5. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. Cancer Res; 2002 Feb 01; 62(3):721-33. PubMed ID: 11830526 [Abstract] [Full Text] [Related]
6. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates. Kaihatsu K, Huffman KE, Corey DR. Biochemistry; 2004 Nov 16; 43(45):14340-7. PubMed ID: 15533038 [Abstract] [Full Text] [Related]
7. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells. Devi GR, Oldenkamp JR, London CA, Iversen PL. Prostate; 2002 Nov 01; 53(3):200-10. PubMed ID: 12386920 [Abstract] [Full Text] [Related]
8. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides. Wolf Y, Pritz S, Abes S, Bienert M, Lebleu B, Oehlke J. Biochemistry; 2006 Dec 19; 45(50):14944-54. PubMed ID: 17154532 [Abstract] [Full Text] [Related]
9. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide. Cogoi S, Codognotto A, Rapozzi V, Meeuwenoord N, van der Marel G, Xodo LE. Biochemistry; 2005 Aug 09; 44(31):10510-9. PubMed ID: 16060660 [Abstract] [Full Text] [Related]
10. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A, Fraizer GC, Piantanelli L, Saunders GF. Anticancer Res; 2001 Aug 09; 21(1A):1-10. PubMed ID: 11299720 [Abstract] [Full Text] [Related]
11. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer. Cutrona G, Carpaneto EM, Ponzanelli A, Ulivi M, Millo E, Scarfì S, Roncella S, Benatti U, Boffa LC, Ferrarini M. Cancer Res; 2003 Oct 01; 63(19):6144-8. PubMed ID: 14559793 [Abstract] [Full Text] [Related]
12. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. Dias N, Dheur S, Nielsen PE, Gryaznov S, Van Aerschot A, Herdewijn P, Hélène C, Saison-Behmoaras TE. J Mol Biol; 1999 Nov 26; 294(2):403-16. PubMed ID: 10610767 [Abstract] [Full Text] [Related]
13. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H. Cancer Gene Ther; 2000 Jul 26; 7(7):997-1007. PubMed ID: 10917202 [Abstract] [Full Text] [Related]
14. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis. Herness EA, Naz RK. Cancer Res; 2003 Jan 15; 63(2):329-36. PubMed ID: 12543784 [Abstract] [Full Text] [Related]
15. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T, Lin FF, Rao P, Lin MF. Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404 [Abstract] [Full Text] [Related]
16. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC. Oncogene; 2003 Aug 28; 22(36):5602-13. PubMed ID: 12944908 [Abstract] [Full Text] [Related]
17. Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cells. Wang XH, Whyzmuzis CA, An S, Chen Y, Wu JM, Schneidau TA, Mallouh C, Tazaki H. Biochem Mol Biol Int; 1994 Aug 28; 34(1):47-53. PubMed ID: 7849624 [Abstract] [Full Text] [Related]
18. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution. Lansiaux A, Tanious F, Mishal Z, Dassonneville L, Kumar A, Stephens CE, Hu Q, Wilson WD, Boykin DW, Bailly C. Cancer Res; 2002 Dec 15; 62(24):7219-29. PubMed ID: 12499262 [Abstract] [Full Text] [Related]
19. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP. Fujinami K, Uemura H, Ishiguro H, Kubota Y. Int J Mol Med; 2002 Aug 15; 10(2):173-6. PubMed ID: 12119554 [Abstract] [Full Text] [Related]
20. Regulation of growth hormone receptors in human prostate cancer cell lines. Bidosee M, Karry R, Weiss-Messer E, Barkey RJ. Mol Cell Endocrinol; 2009 Oct 15; 309(1-2):82-92. PubMed ID: 19540305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]